PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28493985 ↗2017Reported benefit

Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies.

MouseWoundBALB/cFemalen = Five groups of six mice eachTopical application to the wound followed by 650 nm laser illumination50 microlitres of 40 micromolar 4I applied to the wound; in…Applied after wound infection was established

Model: Full-thickness dorsal excisional wound of approximately 1 cm by 1 cm infected with multidrug-resistant Acinetobacter baumannii, in mice immunosuppressed with intraperitoneal cyclophosphamide 150 mg/kg and 100 mg/kg on days 1 and 4 before wounding

4I-mediated photodynamic antimicrobial chemotherapy achieved more than 2.89 log reduction of multidrug-resistant Acinetobacter baumannii at 24 hours after treatment compared with untreated mice and accelerated wound recovery, whereas 4I alone or light alone had no visible antimicrobial effect.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.